Polivy 30 mg

Polatuzumab Vedotin (POLIVY) 30 mg is a powder for solution used in intravenous therapy. This medication is designed to target specific cells in the body, often used in combination with other treatments for certain conditions.

Polatuzumab Vedotin (POLIVY) 30 mg is primarily used in combination with other drugs for the treatment of specific types of cancer. It works by targeting and binding to certain cells, which may help in managing the condition. This medication is often used in cases where other treatments have not been effective.

Common effects of Polatuzumab Vedotin (POLIVY) 30 mg may include fatigue, nausea, and low blood cell counts. Some individuals may also experience fever, infections, or infusion-related reactions. These effects can vary from person to person and may not affect everyone who uses this medication.

Polatuzumab Vedotin (POLIVY) 30 mg should be handled with care and administered by a healthcare professional. It is important to follow the prescribed dosage and administration instructions. Patients should be monitored for any signs of infection or other adverse reactions. Always consult with a healthcare provider before starting this treatment.

Polatuzumab Vedotin (POLIVY) 30 mg may interact with other medications, including those that affect the immune system or blood cell production. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain supplements may also interact with this medication.